This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.




Agilent’s Nucleic Acid Solutions Division (NASD) is located in Boulder, CO where it operates a 77,000 square foot multi-product cGMP oligonucleotide manufacturing facility. The company has acquired a 20 acre plot in Frederick, Colorado where construction of a new pharmaceutical facility will be completed in 2018 and cGMP operations will commence in 2019. The expansion will more than double Agilent’s commercial manufacturing capacity for nucleic acid based therapeutics.